These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 631922)

  • 21. Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity.
    Van Loveren H; Kato K; Meade R; Green DR; Horowitz M; Ptak W; Askenase PW
    J Immunol; 1984 Nov; 133(5):2402-11. PubMed ID: 6332850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contact and delayed hypersensitivity in the mouse. I. Active sensitization and passive transfer.
    Asherson GL; Ptak W
    Immunology; 1968 Sep; 15(3):405-16. PubMed ID: 4177017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement and restoration of contact sensitivity reactions by isoprinosine.
    Rojo JM; Ojeda G; Portolés MP
    J Immunopharmacol; 1983; 5(3):231-43. PubMed ID: 6197488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the genetic control of picryl chloride contact hypersensitivity reaction in inbred rats.
    Nakamura K; Aizawa M
    Transplant Proc; 1981 Jun; 13(2):1400-3. PubMed ID: 7245332
    [No Abstract]   [Full Text] [Related]  

  • 25. Isotype-like suppression of T cell-mediated immunity in vivo. I. Delayed-type hypersensitivity specificity of T cell suppression induced by antigen-binding T cell factors that initiate contact sensitivity.
    Ptak W; Bereta M; Ptak M; Askenase PW
    J Immunol; 1986 Mar; 136(5):1554-63. PubMed ID: 2419404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of cyclophosphamide and irradiation on cells which suppress contact sensitivity in the mouse.
    Zembala M; Asherson GL
    Clin Exp Immunol; 1976 Mar; 23(3):554-61. PubMed ID: 1084814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the ability of T cells to suppress the induction and expression of contact sensitivity.
    Thomas WR; Watkins MC; Asherson GL
    Immunology; 1981 Jan; 42(1):53-9. PubMed ID: 6450730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of immunologic unresponsiveness: a new approach.
    Battisto JR; Bloom BR
    Fed Proc; 1966; 25(1):152-9. PubMed ID: 4143743
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction of tolerance to topically applied TNCB using TNP-conjugated ultraviolet light-irradiated epidermal cells.
    Sauder DN; Tamaki K; Moshell AN; Fujiwara H; Katz SI
    J Immunol; 1981 Jul; 127(1):261-5. PubMed ID: 7240743
    [No Abstract]   [Full Text] [Related]  

  • 30. Isotype-like suppression of T cell-mediated immunity in vivo. II. Suppression of the early component of contact sensitivity by a Ly-2+ T cell-derived suppressor factor that binds to contact sensitivity-initiating, antigen-specific, Ly-1+ T cell-derived factors that are of different antigen specificities.
    Ptak W; Bereta M; Ptak M; Askenase PW
    J Immunol; 1986 Mar; 136(5):1564-70. PubMed ID: 2419405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of tumor growth and enhancement of cell-mediated immunity by an antigen-specific contrasuppressor factor from a T cell hybridoma.
    Friedman AM; Ptak W; Freedman J; Green DR; Flood PM
    Prog Clin Biol Res; 1989; 288():281-8. PubMed ID: 2566176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Suppressor system of cell-mediated hypersensitivity in the mouse:sheep-erythrocyte model].
    Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
    Rev Latinoam Microbiol; 1986; 28(3):211-5. PubMed ID: 2954197
    [No Abstract]   [Full Text] [Related]  

  • 33. Local administration of cytostatic drug 4-hydroperoxy-cyclophosphamide (4-HPCY) facilitates cell-mediated immune reactions.
    Boerrigter GH; Scheper RJ
    Clin Exp Immunol; 1984 Oct; 58(1):161-6. PubMed ID: 6478648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for an inducer-suppressor T cell in the regulation of DTH to alloantigens.
    Molendijk A; van Gurp RJ; Benner R
    Transplant Proc; 1987 Oct; 19(5):4261-4. PubMed ID: 2960054
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings: Further studies on sensitization to picric acid.
    Chase MW; Maguire HC
    Monogr Allergy; 1974; 8(0):1-12. PubMed ID: 4837096
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on contact hypersensitivity in mice and its mechanism].
    Ptak W
    Folia Med Cracov; 1971; 13(1):59-99. PubMed ID: 5568298
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunologic manipulation of DMBA carcinogenesis by DNCB contact hypersensitivity.
    Mohammad AR; Sastry KA; Ruprecht A
    J Oral Med; 1986; 41(1):21-4. PubMed ID: 3083058
    [No Abstract]   [Full Text] [Related]  

  • 38. [Stimulation and suppression of contact dermatitis in mice with a low-molecular thymic humoral factor].
    Malyzheev VA; Valueva TK; Davydova TI
    Biull Eksp Biol Med; 1978 May; 85(5):572-5. PubMed ID: 656604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory lymphoid cells. Cells in immunized lymph nodes that move to sites of inflammation.
    Asherson GL; Allwood GG
    Immunology; 1972 Mar; 22(3):493-502. PubMed ID: 4402113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed hypersensitivity in mast-cell-deficient mice.
    Thomas WR; Schrader JW
    J Immunol; 1983 Jun; 130(6):2565-7. PubMed ID: 6602168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.